Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001183740-23-000009
Filing Date
2023-01-27
Accepted
2023-01-27 17:18:28
Documents
3
Period of Report
2023-01-27

Document Format Files

Seq Description Document Type Size
1 f6k-20230127drug.htm 6-K 5065
2 NEWS RELEASE ex991-20230127drug.htm EX-99.1 8402
3 ex99120230127drug_1.jpg GRAPHIC 2115
  Complete submission text file 0001183740-23-000009.txt   17483
Mailing Address 19 VESTRY STREET NEW YORK NY 10013
Business Address 19 VESTRY STREET NEW YORK NY 10013 6474072515
BRIGHT MINDS BIOSCIENCES INC. (Filer) CIK: 0001827401 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-40997 | Film No.: 23564311
SIC: 2834 Pharmaceutical Preparations